104 related articles for article (PubMed ID: 2820988)
21. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
Nicola AV; Ponce de Leon M; Xu R; Hou W; Whitbeck JC; Krummenacher C; Montgomery RI; Spear PG; Eisenberg RJ; Cohen GH
J Virol; 1998 May; 72(5):3595-601. PubMed ID: 9557640
[TBL] [Abstract][Full Text] [Related]
22. Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines.
Brynestad K; Babbit B; Huang L; Rouse BT
J Virol; 1990 Feb; 64(2):680-5. PubMed ID: 2153234
[TBL] [Abstract][Full Text] [Related]
23. Antibody response to herpes simplex virus glycoprotein D: effects of acyclovir and relation to recurrence.
Bernstein DI; Stanberry LR; Harrison CJ; Shukla R; Kappes JC; Myers MG
J Infect Dis; 1987 Sep; 156(3):423-9. PubMed ID: 3039009
[TBL] [Abstract][Full Text] [Related]
24. Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC(nectin-1) with different affinities.
Connolly SA; Whitbeck JJ; Rux AH; Krummenacher C; van Drunen Littel-van den Hurk S; Cohen GH; Eisenberg RJ
Virology; 2001 Feb; 280(1):7-18. PubMed ID: 11162814
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus type 2 glycoprotein gF and type 1 glycoprotein gC have related antigenic determinants.
Zweig M; Showalter SD; Bladen SV; Heilman CJ; Hampar B
J Virol; 1983 Jul; 47(1):185-92. PubMed ID: 6191040
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant-independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2.
Hazama M; Mayumi-Aono A; Asakawa N; Kuroda S; Hinuma S; Fujisawa Y
Vaccine; 1993; 11(6):629-36. PubMed ID: 8391739
[TBL] [Abstract][Full Text] [Related]
27. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.
Rosenthal KL; Smiley JR; South S; Johnson DC
J Virol; 1987 Aug; 61(8):2438-47. PubMed ID: 3037106
[TBL] [Abstract][Full Text] [Related]
28. Interactions of antigen-sensitized liposomes with immobilized antibody: a homogeneous solid-phase immunoliposome assay.
Ho RJ; Huang L
J Immunol; 1985 Jun; 134(6):4035-40. PubMed ID: 3886794
[TBL] [Abstract][Full Text] [Related]
29. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
[TBL] [Abstract][Full Text] [Related]
30. Antigenic structure of soluble herpes simplex virus (HSV) glycoprotein D correlates with inhibition of HSV infection.
Nicola AV; Peng C; Lou H; Cohen GH; Eisenberg RJ
J Virol; 1997 Apr; 71(4):2940-6. PubMed ID: 9060653
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus glycoprotein D: human monoclonal antibody produced by bone marrow cell line.
Seigneurin JM; Desgranges C; Seigneurin D; Paire J; Renversez JC; Jacquemont B; Micouin C
Science; 1983 Jul; 221(4606):173-5. PubMed ID: 6304881
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.
Harding JA; Engbers CM; Newman MS; Goldstein NI; Zalipsky S
Biochim Biophys Acta; 1997 Jul; 1327(2):181-92. PubMed ID: 9271260
[TBL] [Abstract][Full Text] [Related]
33. Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies.
Liljeqvist JA; Trybala E; Svennerholm B; Jeansson S; Sjögren-Jansson E; Bergström T
J Gen Virol; 1998 May; 79 ( Pt 5)():1215-24. PubMed ID: 9603337
[TBL] [Abstract][Full Text] [Related]
34. Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D.
Nicola AV; Willis SH; Naidoo NN; Eisenberg RJ; Cohen GH
J Virol; 1996 Jun; 70(6):3815-22. PubMed ID: 8648717
[TBL] [Abstract][Full Text] [Related]
35. Transgenic mouse lines that are immunologically tolerant and nontolerant to herpes simplex virus glycoprotein D.
Abramczuk JW; Kearns-Jonker M; Monell-Torrens E; Wohlenberg C; Notkins AL
J Virol; 1991 Nov; 65(11):6124-8. PubMed ID: 1717714
[TBL] [Abstract][Full Text] [Related]
36. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI.
Johnson DC; Frame MC; Ligas MW; Cross AM; Stow ND
J Virol; 1988 Apr; 62(4):1347-54. PubMed ID: 2831396
[TBL] [Abstract][Full Text] [Related]
37. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
Highlander SL; Sutherland SL; Gage PJ; Johnson DC; Levine M; Glorioso JC
J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713
[TBL] [Abstract][Full Text] [Related]
38. Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting.
Cohen GH; Isola VJ; Kuhns J; Berman PW; Eisenberg RJ
J Virol; 1986 Oct; 60(1):157-66. PubMed ID: 2427745
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of heat-sensitive immunoliposomes.
Sullivan SM; Huang L
Biochim Biophys Acta; 1985 Jan; 812(1):116-26. PubMed ID: 3967009
[TBL] [Abstract][Full Text] [Related]
40. A related epitope is consistently present on glycoprotein C of herpes simplex virus type 1 and 2.
Eis-Hübinger AM; Kleim JP; Mohr K; Schneweis KE
Acta Virol; 1991 May; 35(3):276-81. PubMed ID: 1719785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
